Anna Tostevin
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 10%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS drug development and treatment 13
- HIV/AIDS Research and Interventions 11
- SARS-CoV-2 detection and testing 1
- Virology 16
- HIV Research and Treatment 16
- Co-authors
- David Dunn (16 shared papers)Valérie Delpech (5 shared papers)Anton Pozniak (7 shared papers)Caroline Sabin (8 shared papers)Alison Brown (4 shared papers)Deenan Pillay (5 shared papers)Ellen White (4 shared papers)Duncan Churchill (3 shared papers)
- Journals
- HIV Medicine (4 papers)Journal of Antimicrobial Chemotherapy (2 papers)The Journal of Infectious Diseases (2 papers)Clinical Infectious Diseases (1 paper)Epidemics (1 paper)
- Partner nations
- United KingdomSouth AfricaAustralia
In The Last Decade
Anna Tostevin
18 papers receiving 256 citations
Peers
Comparison fields: 5 of 41
- Virology 195
- Infectious Diseases 229
- Epidemiology 74
- Speech and Hearing 13
- Emergency Medicine 17
Countries citing papers authored by Anna Tostevin
This map shows the geographic impact of Anna Tostevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Tostevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Tostevin more than expected).
Fields of papers citing papers by Anna Tostevin
This network shows the impact of papers produced by Anna Tostevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Tostevin. The network helps show where Anna Tostevin may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Tostevin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 55 | |
| 2 | 2018 | 29 | |
| 3 | 2017 | 28 | |
| 4 | 2016 | 21 | |
| 5 | 2017 | 20 | |
| 6 | 2018 | 18 | |
| 7 | 2021 | 17 | |
| 8 | 2020 | 14 | |
| 9 | 2017 | 12 | |
| 10 | 2016 | 9 | |
| 11 | 2019 | 8 | |
| 12 | 2018 | 6 | |
| 13 | 2023 | 5 | |
| 14 | 2020 | 4 | |
| 15 | 2017 | 4 | |
| 16 | 2018 | 3 | |
| 17 | Determining the origins of HIV-1 drug-resistant minority variants in people who are recently infected using phylogenetic reconstruction | 2018 | 3 |
| 18 | 2023 | 2 |
About Anna Tostevin
Anna Tostevin is a scholar working on Infectious Diseases, Virology, Epidemiology, Hepatology and Emergency Medicine, having authored 18 papers that have together received 258 indexed citations. Recurring topics across this work include HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (13 papers), HIV/AIDS Research and Interventions (11 papers), HIV, Drug Use, Sexual Risk (3 papers), Hepatitis C virus research (3 papers), HIV-related health complications and treatments (2 papers), Adolescent and Pediatric Healthcare (1 paper) and SARS-CoV-2 detection and testing (1 paper). The work is most often cited by research in Virology (195 citations), Infectious Diseases (229 citations), Epidemiology (74 citations), Speech and Hearing (13 citations) and Emergency Medicine (17 citations). Anna Tostevin has collaborated with scholars based in United Kingdom, South Africa and Australia. Frequent co-authors include David Dunn, Valérie Delpech, Anton Pozniak, Caroline Sabin, Alison Brown, Deenan Pillay, Ellen White, Duncan Churchill, Erasmus Smit and Oliver Ratmann. Their work appears in journals such as HIV Medicine, Journal of Antimicrobial Chemotherapy, The Journal of Infectious Diseases, Clinical Infectious Diseases and Epidemics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.